199 related articles for article (PubMed ID: 36651103)
1. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19.
Bussani R; Zentilin L; Correa R; Colliva A; Silvestri F; Zacchigna S; Collesi C; Giacca M
J Pathol; 2023 Mar; 259(3):254-263. PubMed ID: 36651103
[TBL] [Abstract][Full Text] [Related]
2. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.
Bussani R; Schneider E; Zentilin L; Collesi C; Ali H; Braga L; Volpe MC; Colliva A; Zanconati F; Berlot G; Silvestri F; Zacchigna S; Giacca M
EBioMedicine; 2020 Nov; 61():103104. PubMed ID: 33158808
[TBL] [Abstract][Full Text] [Related]
3. Pathological post-mortem findings in lungs infected with SARS-CoV-2.
Damiani S; Fiorentino M; De Palma A; Foschini MP; Lazzarotto T; Gabrielli L; Viale PL; Attard L; Riefolo M; D'Errico A
J Pathol; 2021 Jan; 253(1):31-40. PubMed ID: 32930394
[TBL] [Abstract][Full Text] [Related]
4. Salivary glands are a target for SARS-CoV-2: a source for saliva contamination.
Matuck BF; Dolhnikoff M; Duarte-Neto AN; Maia G; Gomes SC; Sendyk DI; Zarpellon A; de Andrade NP; Monteiro RA; Pinho JRR; Gomes-Gouvêa MS; Souza SC; Kanamura C; Mauad T; Saldiva PHN; Braz-Silva PH; Caldini EG; da Silva LFF
J Pathol; 2021 Jul; 254(3):239-243. PubMed ID: 33834497
[TBL] [Abstract][Full Text] [Related]
5. Post-mortem viral dynamics and tropism in COVID-19 patients in correlation with organ damage.
Skok K; Stelzl E; Trauner M; Kessler HH; Lax SF
Virchows Arch; 2021 Feb; 478(2):343-353. PubMed ID: 32815036
[TBL] [Abstract][Full Text] [Related]
6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of SARS-CoV-2 in human post-mortem ocular tissues.
Sawant OB; Singh S; Wright RE; Jones KM; Titus MS; Dennis E; Hicks E; Majmudar PA; Kumar A; Mian SI
Ocul Surf; 2021 Jan; 19():322-329. PubMed ID: 33176215
[TBL] [Abstract][Full Text] [Related]
8. Multisystem screening reveals SARS-CoV-2 in neurons of the myenteric plexus and in megakaryocytes.
Gray-Rodriguez S; Jensen MP; Otero-Jimenez M; Hanley B; Swann OC; Ward PA; Salguero FJ; Querido N; Farkas I; Velentza-Almpani E; Weir J; Barclay WS; Carroll MW; Jaunmuktane Z; Brandner S; Pohl U; Allinson K; Thom M; Troakes C; Al-Sarraj S; Sastre M; Gveric D; Gentleman S; Roufosse C; Osborn M; Alegre-Abarrategui J
J Pathol; 2022 Jun; 257(2):198-217. PubMed ID: 35107828
[TBL] [Abstract][Full Text] [Related]
9. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.
Massoth LR; Desai N; Szabolcs A; Harris CK; Neyaz A; Crotty R; Chebib I; Rivera MN; Sholl LM; Stone JR; Ting DT; Deshpande V
Am J Surg Pathol; 2021 Jan; 45(1):14-24. PubMed ID: 32826529
[TBL] [Abstract][Full Text] [Related]
10. Repeatedly negative PCR results in patients with COVID-19 symptoms: Do they have SARS-CoV-2 infection or not?
Beneš J; Džupová O; Poláková A; Sojková N
Epidemiol Mikrobiol Imunol; 2021; 70(1):3-9. PubMed ID: 33853332
[TBL] [Abstract][Full Text] [Related]
11. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
12. Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components.
El-Baky NA; Amara AA; Uversky VN; Redwan EM
J Cell Biochem; 2024 Jan; 125(1):22-44. PubMed ID: 38098317
[TBL] [Abstract][Full Text] [Related]
13. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients.
Van Slambrouck J; Khan M; Verbeken E; Choi S; Geudens V; Vanluyten C; Feys S; Vanhulle E; Wollants E; Vermeire K; De Fays C; Aversa L; Kaes J; Van Raemdonck D; Vos R; Vanaudenaerde B; De Hertogh G; Wauters E; Wauters J; Ceulemans LJ; Mombaerts P
EBioMedicine; 2023 Jun; 92():104608. PubMed ID: 37224768
[TBL] [Abstract][Full Text] [Related]
14. Post-Mortem RT-PCR Assay for SARS-CoV-2 RNA in COVID-19 Patients' Corneal Epithelium, Conjunctival and Nasopharyngeal Swabs.
Aiello F; Ciotti M; Gallo Afflitto G; Rapanotti MC; Caggiano B; Treglia M; Grelli S; Bernardini S; Mauriello S; Nucci C; Marsella LT; Mancino R
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575369
[TBL] [Abstract][Full Text] [Related]
15. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
[TBL] [Abstract][Full Text] [Related]
16. Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR.
Zito Marino F; De Cristofaro T; Varriale M; Zannini G; Ronchi A; La Mantia E; Campobasso CP; De Micco F; Mascolo P; Municinò M; Municinò E; Vestini F; Pinto O; Moccia M; De Stefano N; Nappi O; Sementa C; Zotti G; Pianese L; Giordano C; Franco R
Virchows Arch; 2022 Mar; 480(3):597-607. PubMed ID: 35103846
[TBL] [Abstract][Full Text] [Related]
17. [SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].
Erensoy S
Mikrobiyol Bul; 2020 Jul; 54(3):497-509. PubMed ID: 32755524
[TBL] [Abstract][Full Text] [Related]
18. Post-mortem CT lung findings at a medicolegal institute in SARS-CoV-2 RT-PCR positive cases with autopsy correlation.
O'Donnell C; Iles L; Woodford N
Forensic Sci Med Pathol; 2021 Dec; 17(4):611-620. PubMed ID: 34160740
[TBL] [Abstract][Full Text] [Related]
19. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J
bioRxiv; 2021 Feb; ():. PubMed ID: 33619488
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
